Fundraising Overview - The company Zhejiang Xidamen New Materials Co., Ltd. successfully completed its initial public offering (IPO) by issuing 24 million shares at a price of RMB 21.17 per share, raising a total of RMB 508.08 million, with a net amount of RMB 455.91 million after deducting issuance costs of RMB 52.17 million [1][2] Fund Management and Usage - The company established a special account for the management and use of the raised funds, in compliance with relevant laws and regulations, to protect investor rights [1][2] - A tripartite supervision agreement was signed with the underwriter and the banks holding the funds, ensuring proper management and usage of the raised capital [1][2] Account Closure - Due to the completion of certain investment projects funded by the IPO, the company decided to close specific fundraising accounts at Zhejiang Shaoxing Ruifeng Rural Commercial Bank and Industrial and Commercial Bank of China, as the funds in these accounts had been fully utilized [2][3] - The closure of these accounts has been completed, and the company has notified the underwriter and relevant parties [3]

为了规范募集资金的管理和使用，提高资金使用效率和效益，保护投资者 权益，本公司按照《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年 修订）》（证监会公告〔2022〕15 号）和《上海证券交易所上市公司自律监管 指引第 1 号——规范运作（2023 年 12 月修订）》（上证发〔2023〕193 号）等 证券代码：605155 证券简称：西大门 公告编号：2025-021 浙江西大门新材料股份有限公司 关于部分募集资金专户销户完成的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江西大门新材料股份有限公司（以下简称"公司"）首次公开发行股票 募集资金按照相关法律、法规、规范性文件的规定在银行开立了募集资金专项 账户。鉴于公司首次公开发行股票募集资金部分投资项目已经结项，公司办理 完成了部分募集资金专项账户的注销手续，具体情况如下： 一、 募集资金基本情况 经中国证券监督管理委员会《关于核准浙江西大门新材料股份有限公司首次 公开发 ...

Group 1 - Kaichun Co., Ltd. adjusted the share repurchase price limit from 26.625 yuan/share to 40 yuan/share, effective from June 10, 2025 [1] - Yipin Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, a Class 3 chemical drug used for sedation during anesthesia [1] - Bohui Innovation obtained a medical device registration certificate for HPV Genotyping Test Kit, used for qualitative detection of HPV DNA [1][2] Group 2 - Lingyi Zhi Zao's application for issuing convertible bonds and cash payment to acquire 66.46% of Jiangsu Kedasiteng Automotive Technology Co., Ltd. has been accepted by the Shenzhen Stock Exchange [3] - Kemin Food reported a 23.06% year-on-year increase in pig sales in May, with a total of 48,300 pigs sold [4][5] - Meian Sen decided to terminate the issuance of shares to specific objects due to market conditions and strategic considerations [6][7] Group 3 - Zhengbang Technology reported a 146.6% year-on-year increase in pig sales revenue in May, totaling 731 million yuan [9] - Yuanda Holdings plans to reduce the registered capital of its subsidiary from 73 million to 24.3 million USD to optimize asset structure [10] - East China Pharmaceutical's subsidiary received FDA approval for clinical trials of HDM1010 tablets for type 2 diabetes [12] Group 4 - Liangxin Co., Ltd. received a government subsidy of 14.1 million yuan, accounting for 4.52% of its audited net profit for 2024 [13] - Erkang Pharmaceutical's Vitamin B6 Injection passed the consistency evaluation for generic drugs [14] - New Industry received a patent certificate for an antibody related to anti-PIC detection, enhancing detection efficiency [16][15] Group 5 - Dongxing Medical signed a 6 million yuan technology development contract with Shanghai Jiao Tong University for collagen preparation processes [16] - Suchang Chai A's subsidiary will absorb and merge another subsidiary, adjusting internal equity structure [17] - Yibin Technology received a project designation notice from a domestic new energy vehicle company, with an estimated total sales of 256 million yuan over five years [18] Group 6 - Mingchen Health received a cash dividend of 20 million yuan from its subsidiary [19] - Hendi Pharmaceutical obtained a drug registration certificate for Ibuprofen Suspension, a common medication for children [19] - Huaren Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, classified as a Category B drug under national medical insurance [20] Group 7 - Enwei Pharmaceutical obtained a renewed drug production license for six key products [21] - Xiaoming Co., Ltd. reported a 45.59% year-on-year increase in chicken product sales in May, totaling 23.25 million birds [23][24] - Shan Natural Gas successfully issued a 350 million yuan short-term financing bond with a 1.78% interest rate [25] Group 8 - Xidamen announced plans for board members to reduce their holdings by up to 581,000 shares [26] - Shentong Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [27] - Saintno Bio plans to distribute a cash dividend of 0.14 yuan per share and a capital increase of 0.4 shares per share [28] Group 9 - *ST King Kong's subsidiary received a debt transfer notice from its controlling shareholder, totaling 364 million yuan [29] - Foxit Software's executives plan to reduce their holdings by a total of 55,800 shares [30] - Youyou Green Energy plans to apply for a bank credit line of up to 1.5 billion yuan [31] Group 10 - Guoxing Optoelectronics plans to distribute a cash dividend of 0.5 yuan per 10 shares [32] - Guangxun Technology plans to distribute a cash dividend of 2.6 yuan per 10 shares [33] - Hanrui Cobalt plans to distribute a cash dividend of 1.5 yuan per 10 shares [35] Group 11 - Tigermed plans to distribute a cash dividend of 3 yuan per 10 shares [37] - Shenliang Holdings plans to distribute a cash dividend of 1.5 yuan per 10 shares [38] - Yishitong plans to distribute a cash dividend of 1 yuan per 10 shares [39]

Core Viewpoint - The announcement from Xidamen indicates a planned reduction in shareholding by key executives and board members, which may impact investor sentiment and stock performance [3]. Group 1: Revenue Composition - For the year 2024, Xidamen's revenue composition is as follows: 57.11% from sunshade fabric manufacturing, 39.72% from sunshade finished products, 2.02% from other manufacturing, and 1.14% from other businesses [1]. Group 2: Shareholding and Reduction Plans - Key executives and board members hold the following shares: Shen Huafeng (1.5 million shares, 0.7821%), Liu Ying (310,000 shares, 0.1608%), and supervisor Bai Jianmin (98,000 shares, 0.0512%) [3]. - The planned share reduction includes: Shen Huafeng (up to 374,500 shares), Liu Ying (up to 7,700 shares), Bai Jianmin (up to 24,500 shares), and senior managers Zhou Li (up to 77,000 shares) and Dong Yuting (up to 28,000 shares) [3]. - The total planned reduction amounts to no more than 581,000 shares, representing approximately 0.3033% of the company's total share capital [3].

Group 1 - Controlling shareholders of Lian De Equipment plan to reduce their holdings by up to 5,401,529 shares, accounting for 3.00% of the total share capital within three months [1] - Controlling shareholders of Doctor Glass plan to reduce their holdings by up to 4,718,494 shares, accounting for 2.69% of the total share capital within three months [1] - Controlling shareholder of Ben Chuan Intelligent plans to reduce their holdings by up to 2,318,900 shares, accounting for 3.00% of the total share capital within three months [1] Group 2 - Shareholder of Hubei Broadcasting plans to reduce their holdings by up to 11,371,400 shares, accounting for 1.00% of the total share capital within three months [1] - Shareholder of Weixing Intelligent plans to reduce their holdings by up to 30,400 shares, accounting for 0.01% of the total share capital within three months [1] Group 3 - Director of Tianzhou Culture plans to reduce their holdings by up to 9,485,100 shares, accounting for 1.16% of the total share capital within three months [2] - Shareholder of Hongbo Pharmaceutical plans to reduce their holdings by up to 1,370,000 shares, accounting for 1.00% of the total share capital after excluding repurchased shares [2] - Shareholder of Oujing Technology plans to reduce their holdings by up to 577,220 shares, accounting for 3.00% of the total share capital within three months [2] Group 4 - Shareholders of Longhua New Materials plan to reduce their holdings by up to 990,000 shares and 61,000 shares, accounting for 0.2302% and 0.0142% of the total share capital respectively within three months [2] Group 5 - Shareholder of Desai Xiwai plans to reduce their holdings by up to 16,400,000 shares, accounting for 3.00% of the total share capital within three months [3] - Shareholder of Tongyou Technology plans to reduce their holdings by up to 4,792,637 shares, accounting for 1.00% of the total share capital within three months [3] - Shareholders of Xice Testing plan to reduce their holdings by a total of 592,000 shares, accounting for 0.7014% of the total share capital within three months [3] Group 6 - Director of Kede Education plans to reduce their holdings by up to 1,501,875 shares, accounting for 0.4563% of the total share capital within three months [3] - Shareholder of Jianke Institute plans to reduce their holdings by up to 1,466,600 shares, accounting for 1.00% of the total share capital within three months [4] - Shareholder of Ruantong Power plans to reduce their holdings by up to 9,529,300 shares, accounting for 1.00% of the total share capital within three months [4] Group 7 - Shareholder of Tianli Lithium Energy has not reduced their holdings during the specified period [4] - Shareholders of Dongli Machinery plan to reduce their holdings by up to 4,330,534 shares, accounting for 3.00% of the total share capital within three months [4] - Shareholders of Zhongzhou Holdings plan to reduce their holdings by a total of 8,357,544 shares, accounting for 4.999998% of the total share capital [5] Group 8 - Shareholder of Online and Offline plans to reduce their holdings by up to 2,000,000 shares, accounting for 2.51% of the total share capital after excluding repurchased shares [5] - Shareholders of Puli Software plan to reduce their holdings by up to 1,957,500 shares, accounting for 0.70% of the total share capital within three months [5] - Shareholder of Yisheng Pharmaceutical plans to reduce their holdings by up to 416,179 shares, accounting for 0.1258% of the total share capital within three months [5] Group 9 - Shareholders of Gaomeng New Materials plan to reduce their holdings by up to 9,834,608 shares, accounting for 2.282% of the total share capital within three months [6] - Shareholder of Wenke Co. plans to reduce their holdings by up to 9,639,121 shares, accounting for 1.60% of the total share capital within three months [6] - Shareholder of Nanling Technology plans to reduce their holdings by a total of 197,400 shares, accounting for 0.1499% of the total share capital [6] Group 10 - Shareholders of Tianfang Biao plan to reduce their holdings through various methods, with total reductions accounting for 1.00% of the total share capital [6] - Shareholders of Shenyu Co. plan to reduce their holdings by up to 1,747,700 shares, accounting for 0.99% of the total share capital within three months [7] - Shareholder of Jindan Technology plans to reduce their holdings by up to 563,500 shares, accounting for 2.93% of the total share capital within three months [7] Group 11 - Shareholder of Bochuang Technology plans to reduce their holdings by up to 1,710,000 shares, accounting for 0.59% of the total share capital within three months [7] - Shareholder of Chuangwei Digital plans to reduce their holdings by a total of 9,000,000 shares, accounting for 0.788% of the total share capital within three months [8] - Shareholders of Keri International plan to reduce their holdings by various amounts, with total reductions accounting for 0.0238% to 0.1059% of the total share capital [8] Group 12 - Shareholders of Xingchen Technology plan to reduce their holdings by up to 10,526,500 shares, accounting for 2.5% of the total share capital within three months [9] - Shareholder of Changyang Technology plans to reduce their holdings by up to 1,920,000 shares, accounting for 0.67% of the total share capital within three months [9] - Shareholders of Fuxin Software plan to reduce their holdings by various amounts, with total reductions accounting for 0.0547% to 0.0063% of the total share capital [10] Group 13 - Shareholder of Hainan Haiyao plans to reduce their holdings by 15,573,600 shares, accounting for 1.2004% of the total share capital [10] - Shareholder of Ruoyuchen plans to reduce their holdings by up to 4,768,071 shares, accounting for 3.00% of the total share capital within three months [10] - Shareholders of Fuxin Technology plan to reduce their holdings by various amounts, with total reductions accounting for 1.4959% to 0.0198% of the total share capital [11] Group 14 - Shareholder of Liming Co. plans to reduce their holdings by various amounts, with total reductions accounting for 0.43% to 0.07% of the total share capital [11] - Shareholder of Huazhu High-Tech plans to reduce their holdings by up to 9,111,714 shares, accounting for 2.20% of the total share capital within three months [11] - Shareholder of Yongda Co. plans to reduce their holdings by up to 7,200,000 shares, accounting for 3.00% of the total share capital within three months [12] Group 15 - Shareholder of Del Shares plans to reduce their holdings by up to 3,000,000 shares, accounting for 1.987% of the total share capital within three months [12] - Shareholder of Artis plans to reduce their holdings by up to 36,882,173 shares through various methods, accounting for 1% of the total share capital [12] - Shareholder of Xidamen plans to reduce their holdings by various amounts, with total reductions accounting for 0.1955% to 0.0402% of the total share capital [13] Group 16 - Shareholder of Huicheng Vacuum plans to reduce their holdings by up to 2,500,000 shares, accounting for 2.50% of the total share capital within three months [13] - Shareholder of Shentong Technology plans to reduce their holdings by up to 12,880,640 shares, accounting for 3.00% of the total share capital within three months [13] - Shareholder of Mindong Electric Power plans to reduce their holdings by up to 4,579,514 shares, accounting for 1.00% of the total share capital within the specified period [14] Group 17 - Shareholders of Juxin Technology plan to reduce their holdings by various amounts, with total reductions accounting for 1.00% of the total share capital [14] - Shareholder of Zhonggu Logistics plans to reduce their holdings by up to 2.45% and 0.55% of the total share capital within three months [15] - Shareholder of Aotai Bio plans to reduce their holdings by up to 388,400 shares, accounting for 0.4899% of the total share capital [15] Group 18 - Shareholder of Guotai Group plans to reduce their holdings by up to 0.266% of the total share capital within three months [15] - Shareholder of Shanghai Construction plans to reduce their holdings by up to 24,419,665 shares, accounting for 0.27% of the total share capital within the specified period [16]

Group 1 - The company Zhejiang Xidamen New Materials Co., Ltd. announced a share reduction plan by its directors and senior management [1][2] - The total number of shares to be reduced is up to 581,000 shares, accounting for approximately 0.3033% of the company's total share capital [2] - The reduction period is set for three months starting from 15 trading days after the announcement, excluding any periods where reductions are prohibited [2] Group 2 - The directors and senior management involved in the reduction include Shen Huafeng, Liu Ying, Bai Jianmin, Zhou Li, and Dong Yuting, with specific shareholding percentages detailed [1][2] - The planned reduction amounts for each individual are specified, with Shen Huafeng and Liu Ying planning to reduce 374,500 shares and 77,000 shares respectively [2] - The reduction will be conducted through centralized bidding, and the price will be determined based on market conditions at the time of the reduction [2][3]

证券代码：605155 证券简称：西大门 公告编号：2025-020 浙江西大门新材料股份有限公司 董监高减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 董监高持股的基本情况:浙江西大门新材料股份有限公司（以下简称"公 司"）董事兼副总经理沈华锋先生、柳英女士分别持有公司股份 1,498,000 股、 308,000 股，分别占公司股份总数的 0.7821%、0.1608%；监事柏建民先生直接持 有公司股份 98,000 股，占公司股份总数的 0.0512%；高级管理人员周莉女士、董 雨亭女士分别持有公司股份 308,000 股、112,000 股，分别占公司股份总数的 0.1608%、0.0585%。 减持计划的主要内容：减持期间为自本公告披露之日起 15 个交易日后的 未来 3 个月内（根据中国证监会及上海证券交易所规定禁止减持的期间除外）。 公司董事兼副总经理沈华锋先生、柳英女士计划通过集中竞价交易方式减持公司 股份，减持数量分别不超过 374,500 股、77,00 股；监事 ...

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative return of over 20% within the next six months [5][17]. Core Insights - The company achieved a revenue of 190 million in Q1 2025, a year-on-year increase of 13%, while the net profit attributable to the parent company was 23 million, down 1% year-on-year. For 2024, the company is projected to achieve a revenue of 820 million, up 28% year-on-year, with a net profit of 120 million, up 34% year-on-year [1]. - The company has a strong order backlog of 2-3 months, indicating robust demand and the ability to dynamically adjust production capacity based on orders [1]. - The company has successfully expanded its global sales network, particularly in North America and Europe, leading to a significant increase in revenue from regions outside mainland China, which grew by 48% year-on-year [2]. - The company is enhancing its brand marketing capabilities and expanding its marketing channels, including the establishment of overseas warehouses to improve logistics efficiency and customer service [3]. Financial Performance - The company's revenue is expected to grow from 637.33 million in 2023 to 1,663.08 million by 2027, with a compound annual growth rate (CAGR) of approximately 27.69% [10]. - The net profit attributable to the parent company is projected to increase from 91.14 million in 2023 to 242.05 million by 2027, reflecting a strong growth trajectory [10]. - The company's earnings per share (EPS) is expected to rise from 0.48 in 2023 to 1.26 in 2027, indicating improving profitability [10]. Strategic Initiatives - The company has completed the main construction of its "New Material Expansion Project" for building shading, which will support future sales growth by increasing production capacity [2]. - A stock incentive plan has been implemented to bind key personnel, with performance targets set for revenue growth over the next three years, reflecting confidence in the company's future performance [4].

Group 1 - The company held its 26th meeting of the third board of directors on May 21, 2025, where all 7 directors attended, ensuring the meeting's legality and validity [2][3] - The board approved the adjustment of the repurchase price for the 2023 restricted stock incentive plan from 4.64 yuan per share to 4.39 yuan per share due to a cash dividend distribution of 2.50 yuan per 10 shares [2][32][36] - The board also approved the achievement of the second unlock condition for the 2023 restricted stock incentive plan, allowing 68 eligible individuals to apply for the release of 837,060 shares, which represents 0.44% of the company's total shares [18][25][26] Group 2 - The company will repurchase and cancel 249,340 shares of restricted stock due to 29 individuals not meeting performance assessment standards [6][51][52] - The repurchase price for the canceled shares is set at 4.39 yuan per share, and the process has been approved by the board [47][53] - The company confirmed that the adjustments and cancellations will not materially affect its financial status or operational results [42][55]

Core Points - The second unlock period of the 2023 restricted stock incentive plan has met the conditions for unlocking [1][4] - A total of 68 individuals are eligible for the unlocking of restricted stocks [1][8] - The number of restricted stocks that can be unlocked in this period is 837,060 shares, accounting for 0.44% of the company's total share capital [1][8] Summary by Sections Incentive Plan Overview - The company has implemented a 2023 restricted stock incentive plan, which includes various resolutions approved by the board and supervisory committee [2][3] - Independent opinions were provided by the independent directors regarding the incentive plan [2] Conditions for Unlocking - The second unlock period is defined as starting from the first trading day after 24 months from the completion of the restricted stock grant registration, lasting until the last trading day within 36 months [4] - The completion date for the registration of the 2023 restricted stock incentive plan was July 13, 2023, with the first unlock period ending on July 14, 2025 [4] Performance Conditions - The company achieved a cumulative audited revenue of approximately 637.33 million yuan for the 2023-2024 period, exceeding the target of 1.42 billion yuan [6] - The performance conditions for individual incentive objects were also met, with 49 out of 79 individuals achieving an "A" performance rating, allowing for a 100% unlocking ratio [6][7] Unlocking Details - The total number of restricted stocks eligible for unlocking is 837,060 shares, distributed among 68 eligible individuals [8][9] - Specific individuals, such as the vice general managers and the financial director, have significant portions of their restricted stocks eligible for unlocking [8][9] Approval and Legal Opinions - The board's remuneration and assessment committee confirmed that the conditions for unlocking have been met [9] - Legal opinions affirm that all necessary approvals and authorizations for the unlocking process have been obtained, complying with relevant regulations [9]